Bone marrow (BM) is a clinically relevant site of micrometastatic disease in patients with
solid epithelial tumors. It is, therefore, important to establish suitable models that allow the in-…

Epstein-Barr virus (EBV) establishes lifelong persistent infections in humans by latently
infecting B cells, with occasional cycles of reactivation, virus production, and reinfection. …

Although micrometastatic cancer cells in lymph nodes can be detected by monoclonal
antibodies against epithelial or tumor-associated antigens,it remains unclear whether these cells …

Background Epstein-Barr virus (EBV) is associated with a number of human malignancies.
EBV-positive post-transplant lymphoproliferative disease in solid organ and hematopoietic …

Objectives T follicular helper (Tfh) cells are the principal T helper cell subset that provides
help to B cells for potent antibody responses against various pathogens. In this study, we took …

T cell immunity is crucial for control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection and has been studied widely on a quantitative level. However, the …

The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2
antigens remains poorly understood. Conventional methods to detect antigen-…

T-cell therapy of chronic hepatitis B is a novel approach to restore antiviral T-cell immunity
and cure the infection. We aimed at identifying T-cell receptors (TCR) with high functional …

The Epstein‐Barr virus (EBV) nuclear antigen 1 (EBNA1) is the only viral protein regularly
expressed in EBV‐associated malignancies. Immune recognition of EBNA1 by CD8 + T cells …

Polyclonal Epstein-Barr virus (EBV)-infected B cell line (lymphoblastoid cell lines; LCL)-stimulated
T-cell preparations have been successfully used to treat EBV-positive post-transplant …